NCT01290393 2018-07-26Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in CanadaGlaxoSmithKlineTerminated2 enrolled
NCT01905462 2013-09-30Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix Residing in UKGlaxoSmithKlineCompleted1,046 enrolled